Latest ARMISTICE CAPITAL, LLC Stock Portfolio

ARMISTICE CAPITAL, LLC Performance:

2024 Q4: 0.03%YTD: -7.4%2023: -1.65%

Performance for 2024 Q4 is 0.03%, and YTD is -7.4%, and 2023 is -1.65%.

About ARMISTICE CAPITAL, LLC and 13F Hedge Fund Stock Holdings

ARMISTICE CAPITAL, LLC is a hedge fund based in NEW YORK, NY. On 31-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $5.6 Billions. In it's latest 13F Holdings report, ARMISTICE CAPITAL, LLC reported an equity portfolio of $7.3 Billions as of 31 Dec, 2024.

The top stock holdings of ARMISTICE CAPITAL, LLC are PTCT, SUPN, TVTX. The fund has invested 3.9% of it's portfolio in PTC THERAPEUTICS INC and 2.4% of portfolio in SUPERNUS PHARMACEUTICALS INC.

The fund managers got completely rid off ALKERMES PLC (ALKS), DOCUSIGN INC (DOCU) and PARAMOUNT GLOBAL (PARA) stocks. They significantly reduced their stock positions in SAVERONE 2014 LTD, JEFFS BRANDS LTD (JFBR) and VINCERX PHARMA INC (VINC). ARMISTICE CAPITAL, LLC opened new stock positions in EXACT SCIENCES CORP (EXAS), ICON PLC and CENTRAL GARDEN & PET CO (CENT). The fund showed a lot of confidence in some stocks as they added substantially to MONSTER BEVERAGE CORP NEW (MNST), ILLUMINA INC (ILMN) and SCILEX HOLDING CO.

ARMISTICE CAPITAL, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that ARMISTICE CAPITAL, LLC made a return of 0.03% in the last quarter. In trailing 12 months, it's portfolio return was -7.4%.

New Buys

Ticker	$ Bought
exact sciences corp	90,859,200
icon plc	87,682,300
central garden & pet co	26,299,900
mccormick & co inc	20,061,600
e l f beauty inc	19,387,300
nebius group n.v.	15,537,200
sharkninja inc	13,418,300
belite bio inc	10,596,400

New stocks bought by ARMISTICE CAPITAL, LLC

Additions

Ticker	% Inc.
monster beverage corp new	2,966
illumina inc	883
scilex holding co	409
neurocrine biosciences inc	391
nomad foods ltd	391
vertex pharmaceuticals inc	385
gsk plc	353
cyclacel pharmaceuticals inc	300

Additions to existing portfolio by ARMISTICE CAPITAL, LLC

Reductions

Ticker	% Reduced
saverone 2014 ltd	-94.44
jeffs brands ltd	-92.31
kwesst micro systems inc	-90.00
airship ai hldgs inc	-86.24
vincerx pharma inc	-79.03
chipotle mexican grill inc	-71.53
livanova plc	-68.91
evaxion biotech a/s	-68.85

ARMISTICE CAPITAL, LLC reduced stake in above stock

Sold off

Ticker	$ Sold
p3 health partners inc	-2,568,900
ondas hldgs inc	-3,662,250
aim immunotech inc	-1,169,100
worksport ltd	-1,278,010
rani therapeutics hldgs inc	-5,559,840
eledon pharmaceuticals inc	-5,886,360
mobix labs inc	-2,476,160
paramount global	-21,240,000

ARMISTICE CAPITAL, LLC got rid off the above stocks

Sector Distribution

ARMISTICE CAPITAL, LLC has about 52.8% of it's holdings in Healthcare sector.

Sector	%
Healthcare	52.8
Others	18.3
Consumer Cyclical	10.2
Technology	8.6
Consumer Defensive	6.9

Market Cap. Distribution

ARMISTICE CAPITAL, LLC has about 27.9% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
MID-CAP	32.2
LARGE-CAP	23.3
UNALLOCATED	19.6
SMALL-CAP	17.2
MEGA-CAP	4.6
MICRO-CAP	2.3

Stocks belong to which Index?

About 58.5% of the stocks held by ARMISTICE CAPITAL, LLC either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	41.5
RUSSELL 2000	38.4
S&P 500	20.1

Top 5 Winners (%)		%
MNTS	momentus inc	1200.0 %
CTM	castellum inc	1076.5 %
IVDA	iveda solutions inc	965.3 %
CMRX	chimerix inc	274.2 %
NXL	nexalin technology inc	241.5 %

Top 5 Winners ($)		$
PTCT	ptc therapeutics inc	56.5 M
TVTX	travere therapeutics inc	26.3 M
SUPN	supernus pharmaceuticals inc	25.2 M
FIVN	five9 inc	22.6 M
NARI	inari med inc	17.8 M

Top 5 Losers (%)		%
STSS	sharps technology inc	-96.4 %
BIAF	bioaffinity technologies inc	-70.8 %
VINC	vincerx pharma inc	-60.5 %
CEAD	cea industries inc	-60.2 %
TNON	tenon medical inc	-57.7 %

Top 5 Losers ($)		$
KURA	kura oncology inc	-51.4 M
AGIO	agios pharmaceuticals inc	-26.2 M
XRAY	dentsply sirona inc	-21.9 M
BCYC	bicycle therapeutics plc	-18.7 M
IMVT	immunovant inc	-14.5 M

ARMISTICE CAPITAL, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of ARMISTICE CAPITAL, LLC

ARMISTICE CAPITAL, LLC has 227 stocks in it's portfolio. About 17.5% of the portfolio is in top 10 stocks. KURA proved to be the most loss making stock for the portfolio. PTCT was the most profitable stock for ARMISTICE CAPITAL, LLC last quarter.

Last Reported on: 14 Feb, 2025

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
AAL	american airls group inc	0.00	0.00	0.00	sold off	-100

ABNB	airbnb inc	0.00	0.00	0.00	sold off	-100

ACON	aclarion inc	0.00	34,375	688	unchanged	0.00

ADBE	adobe inc	0.41	68,012	30,243,600	added	116

AGIO	agios pharmaceuticals inc	1.01	2,264,300	74,405,000	added	2.59

AGLE	spyre therapeutics inc	0.06	200,000	4,656,000	added	47.06

AIM	aim immunotech inc	0.00	0.00	0.00	sold off	-100

AIMD	ainos inc	0.00	5,000	249	new

ALGS	aligos therapeutics inc	0.00	0.00	0.00	sold off	-100

ALKS	alkermes plc	0.00	0.00	0.00	sold off	-100

AMZN	amazon com inc	0.55	185,102	40,609,500	added	67.49

ANF	abercrombie & fitch co	0.00	0.00	0.00	sold off	-100

ANGO	angiodynamics inc	0.11	872,000	7,987,520	reduced	-9.36

ANY	sphere 3d corp new	0.03	2,174,000	2,052,690	new

APCX	apptech pmts corp	0.00	715,000	85,800	unchanged	0.00

APCX	apptech pmts corp	0.00	0.00	0.00	sold off	-100

APLE	apple hospitality reit inc	0.06	274,407	4,212,150	new

APP	applovin corp	0.03	6,146	1,990,260	new

APTO	aptose biosciences inc	0.00	0.00	0.00	sold off	-100

ARAY	accuray inc	0.03	1,236,000	2,447,280	added	147